Logo image of ECOR

ELECTROCORE INC (ECOR) Stock Fundamental Analysis

NASDAQ:ECOR - Nasdaq - US28531P2020 - Common Stock - Currency: USD

14.71  -0.51 (-3.35%)

Premarket: 15.44 +0.73 (+4.96%)

Fundamental Rating

3

Taking everything into account, ECOR scores 3 out of 10 in our fundamental rating. ECOR was compared to 188 industry peers in the Health Care Equipment & Supplies industry. ECOR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ECOR shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ECOR had negative earnings in the past year.
ECOR had a negative operating cash flow in the past year.
ECOR had negative earnings in each of the past 5 years.
ECOR had a negative operating cash flow in each of the past 5 years.
ECOR Yearly Net Income VS EBIT VS OCF VS FCFECOR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M -40M -50M

1.2 Ratios

ECOR has a worse Return On Assets (-60.30%) than 73.12% of its industry peers.
Looking at the Return On Equity, with a value of -134.21%, ECOR is doing worse than 70.97% of the companies in the same industry.
Industry RankSector Rank
ROA -60.3%
ROE -134.21%
ROIC N/A
ROA(3y)-82.22%
ROA(5y)-89.72%
ROE(3y)-143.24%
ROE(5y)-143.6%
ROIC(3y)N/A
ROIC(5y)N/A
ECOR Yearly ROA, ROE, ROICECOR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

ECOR's Gross Margin of 83.32% is amongst the best of the industry. ECOR outperforms 95.16% of its industry peers.
In the last couple of years the Gross Margin of ECOR has grown nicely.
The Profit Margin and Operating Margin are not available for ECOR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 83.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.95%
GM growth 5Y14.78%
ECOR Yearly Profit, Operating, Gross MarginsECOR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K

More info and screens

5

2. Health

2.1 Basic Checks

ECOR does not have a ROIC to compare to the WACC, probably because it is not profitable.
ECOR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ECOR has been increased compared to 5 years ago.
ECOR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ECOR Yearly Shares OutstandingECOR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
ECOR Yearly Total Debt VS Total AssetsECOR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

ECOR has an Altman-Z score of -7.01. This is a bad value and indicates that ECOR is not financially healthy and even has some risk of bankruptcy.
ECOR has a Altman-Z score of -7.01. This is in the lower half of the industry: ECOR underperforms 74.19% of its industry peers.
ECOR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.01
ROIC/WACCN/A
WACC8.93%
ECOR Yearly LT Debt VS Equity VS FCFECOR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

2.3 Liquidity

A Current Ratio of 2.12 indicates that ECOR has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.12, ECOR is doing worse than 65.05% of the companies in the same industry.
A Quick Ratio of 1.87 indicates that ECOR should not have too much problems paying its short term obligations.
ECOR's Quick ratio of 1.87 is in line compared to the rest of the industry. ECOR outperforms 45.70% of its industry peers.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.87
ECOR Yearly Current Assets VS Current LiabilitesECOR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

ECOR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.35%, which is quite impressive.
The Revenue has grown by 74.08% in the past year. This is a very strong growth!
Measured over the past years, ECOR shows a very strong growth in Revenue. The Revenue has been growing by 74.53% on average per year.
EPS 1Y (TTM)56.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.41%
Revenue 1Y (TTM)74.08%
Revenue growth 3Y66.07%
Revenue growth 5Y74.53%
Sales Q2Q%45.39%

3.2 Future

ECOR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.89% yearly.
ECOR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 36.64% yearly.
EPS Next Y56.13%
EPS Next 2Y35.95%
EPS Next 3Y27.89%
EPS Next 5YN/A
Revenue Next Year58.89%
Revenue Next 2Y48.34%
Revenue Next 3Y48.23%
Revenue Next 5Y36.64%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ECOR Yearly Revenue VS EstimatesECOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M
ECOR Yearly EPS VS EstimatesECOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -5 -10 -15 -20 -25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ECOR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ECOR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ECOR Price Earnings VS Forward Price EarningsECOR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECOR Per share dataECOR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as ECOR's earnings are expected to grow with 27.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.95%
EPS Next 3Y27.89%

More info and screens

0

5. Dividend

5.1 Amount

ECOR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ELECTROCORE INC

NASDAQ:ECOR (3/3/2025, 8:00:00 PM)

Premarket: 15.44 +0.73 (+4.96%)

14.71

-0.51 (-3.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)03-11 2025-03-11/amc
Inst Owners18.95%
Inst Owner Change-43.25%
Ins Owners18.26%
Ins Owner Change1.51%
Market Cap96.35M
Analysts83.64
Price Target24.99 (69.88%)
Short Float %2.45%
Short Ratio0.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.04%
Min EPS beat(2)9.28%
Max EPS beat(2)14.8%
EPS beat(4)4
Avg EPS beat(4)10.88%
Min EPS beat(4)1.56%
Max EPS beat(4)17.87%
EPS beat(8)5
Avg EPS beat(8)1.73%
EPS beat(12)5
Avg EPS beat(12)-1.94%
EPS beat(16)8
Avg EPS beat(16)1.56%
Revenue beat(2)1
Avg Revenue beat(2)3.64%
Min Revenue beat(2)-1.04%
Max Revenue beat(2)8.33%
Revenue beat(4)3
Avg Revenue beat(4)5.43%
Min Revenue beat(4)-1.04%
Max Revenue beat(4)11.95%
Revenue beat(8)5
Avg Revenue beat(8)4.47%
Revenue beat(12)7
Avg Revenue beat(12)2.37%
Revenue beat(16)9
Avg Revenue beat(16)1.64%
PT rev (1m)0%
PT rev (3m)-7.55%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.13
P/FCF N/A
P/OCF N/A
P/B 10.19
P/tB 10.19
EV/EBITDA N/A
EPS(TTM)-1.82
EYN/A
EPS(NY)-0.54
Fwd EYN/A
FCF(TTM)-1.35
FCFYN/A
OCF(TTM)-1.35
OCFYN/A
SpS3.56
BVpS1.44
TBVpS1.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -60.3%
ROE -134.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 83.32%
FCFM N/A
ROA(3y)-82.22%
ROA(5y)-89.72%
ROE(3y)-143.24%
ROE(5y)-143.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.95%
GM growth 5Y14.78%
F-Score6
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.12
Quick Ratio 1.87
Altman-Z -7.01
F-Score6
WACC8.93%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.41%
EPS Next Y56.13%
EPS Next 2Y35.95%
EPS Next 3Y27.89%
EPS Next 5YN/A
Revenue 1Y (TTM)74.08%
Revenue growth 3Y66.07%
Revenue growth 5Y74.53%
Sales Q2Q%45.39%
Revenue Next Year58.89%
Revenue Next 2Y48.34%
Revenue Next 3Y48.23%
Revenue Next 5Y36.64%
EBIT growth 1Y38.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year63.4%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y47.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.14%
OCF growth 3YN/A
OCF growth 5YN/A